Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

721 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.
Chung SK, Vargas DB, Chandler CS, Katugampola S, Veach DR, McDevitt MR, Seo SH, Vaughn BA, Rinne SS, Punzalan B, Patel M, Xu H, Guo HF, Zanzonico PB, Monette S, Yang G, Ouerfelli O, Nash GM, Cercek A, Fung EK, Howell RW, Larson SM, Cheal SM, Cheung NV. Chung SK, et al. J Nucl Med. 2023 Sep;64(9):1439-1445. doi: 10.2967/jnumed.122.265095. Epub 2023 Jun 22. J Nucl Med. 2023. PMID: 37348919 Free PMC article.
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis.
Chandler CS, Bell MM, Chung SK, Veach DR, Fung EK, Punzalan B, Burnes Vargas D, Patel M, Xu H, Guo HF, Santich BH, Zanzonico PB, Monette S, Nash GM, Cercek A, Jungbluth A, Pandit-Taskar N, Cheung NKV, Larson SM, Cheal SM. Chandler CS, et al. Among authors: chung sk. Mol Cancer Ther. 2022 Jan;21(1):125-137. doi: 10.1158/1535-7163.MCT-21-0353. Epub 2021 Oct 19. Mol Cancer Ther. 2022. PMID: 34667111 Free PMC article.
Pretargeting: A Path Forward for Radioimmunotherapy.
Cheal SM, Chung SK, Vaughn BA, Cheung NV, Larson SM. Cheal SM, et al. Among authors: chung sk. J Nucl Med. 2022 Sep;63(9):1302-1315. doi: 10.2967/jnumed.121.262186. J Nucl Med. 2022. PMID: 36215514 Free article. Review.
Molecular Classification of Appendiceal Adenocarcinoma.
Foote MB, Walch H, Chatila W, Vakiani E, Chandler C, Steinruecke F, Nash GM, Stadler Z, Chung S, Yaeger R, Braghrioli MI, Shia J, Kemel Y, Maio A, Sheehan M, Rousseau B, Argilés G, Berger M, Solit D, Schultz N, Diaz LA Jr, Cercek A. Foote MB, et al. J Clin Oncol. 2023 Mar 10;41(8):1553-1564. doi: 10.1200/JCO.22.01392. Epub 2022 Dec 9. J Clin Oncol. 2023. PMID: 36493333 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 37199733
The Impact of Germline Alterations in Appendiceal Adenocarcinoma.
Foote MB, Walch H, Kemel Y, Vakiani E, Johannet P, Sheehan M, Chatila W, Chung S, Nash GM, Maio A, Shia J, Mandelker D, Berger M, Schultz N, Diaz LA, Cercek A, Stadler ZK. Foote MB, et al. Clin Cancer Res. 2023 Jul 14;29(14):2631-2637. doi: 10.1158/1078-0432.CCR-22-3956. Clin Cancer Res. 2023. PMID: 37289003 Free PMC article.
Patient's Perspective on Psychiatric Drugs: A Multicenter Survey-Based Study.
Han S, Kim SY, Jung YE, Kim W, Seo JS, Sohn I, Lee K, Lee JH, Chung SK, Lee SY, Hong JW, Yoon BH, Woo YS, Han C, Chang JG, Bahk WM, Song HR, Hong M. Han S, et al. Among authors: chung sk. Psychiatry Investig. 2024 Jan;21(1):28-36. doi: 10.30773/pi.2023.0049. Epub 2023 Dec 20. Psychiatry Investig. 2024. PMID: 38114066 Free PMC article.
721 results